D T Bishop

Summary

Affiliation: Imperial Cancer Research Fund
Country: UK

Publications

  1. pmc Proximal and progressive: adenomas in HNPCC
    D T Bishop
    ICRF Genetic Epidemiology Division, ICRF Clinical Centre in Leeds, Cancer Genetics Building, St James s University Hospital, Beckett Street, Leeds LS9 7TF, UK
    Gut 50:291-2. 2002
  2. ncbi BRCA1 and BRCA2 and breast cancer incidence: a review
    D T Bishop
    ICRF Genetic Epidemiology Laboratory, Leeds, UK
    Ann Oncol 10:113-9. 1999
  3. pmc Germline BRCA2 mutations in men with breast cancer
    E Mavraki
    Imperial Cancer Research Fund, Genetic Epidemiology, St James s Hospital, Leeds, UK
    Br J Cancer 76:1428-31. 1997
  4. pmc A retrospective observational study of the relationship between family history and survival from colorectal cancer
    E J A Morris
    Colorectal Cancer Epidemiology Group, Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK
    Br J Cancer 108:1502-7. 2013
  5. pmc The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder
    S C Sak
    Molecular Radiobiology Group, Cancer Research UK Clinical Centre in Leeds, St James s University Hospital, Leeds LS9 7TF, UK
    Br J Cancer 92:2262-5. 2005
  6. pmc Association between family history and mismatch repair in colorectal cancer
    R P Coggins
    Cancer Research UK Genetic Epidemiology Laboratory, St James s University Hospital, Beckett St, Leeds LS9 7TF, UK
    Gut 54:636-42. 2005
  7. pmc Plasma osteopontin concentrations in patients with cutaneous melanoma
    A Filia
    Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, St James s University Hospital, Leeds LS9 7TF, UK
    Oncol Rep 30:1575-80. 2013
  8. ncbi Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
    J A Bishop
    ICRF Genetic Epidemiology Laboratory, Leeds, UK
    J Invest Dermatol 114:28-33. 2000
  9. pmc Melanoma sentinel node biopsy and prediction models for relapse and overall survival
    A Mitra
    Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, St James s University Hospital, Beckett Street, Leeds LS97TF, UK
    Br J Cancer 103:1229-36. 2010
  10. ncbi A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
    J A Randerson-Moor
    ICRF Genetic Epidemiology Division, ICRF Clinical Centre in Leeds, Cancer Genetics Building, St James s University Hospital, Beckett Street, Leeds LS9 7TF, UK
    Hum Mol Genet 10:55-62. 2001

Collaborators

Detail Information

Publications15

  1. pmc Proximal and progressive: adenomas in HNPCC
    D T Bishop
    ICRF Genetic Epidemiology Division, ICRF Clinical Centre in Leeds, Cancer Genetics Building, St James s University Hospital, Beckett Street, Leeds LS9 7TF, UK
    Gut 50:291-2. 2002
  2. ncbi BRCA1 and BRCA2 and breast cancer incidence: a review
    D T Bishop
    ICRF Genetic Epidemiology Laboratory, Leeds, UK
    Ann Oncol 10:113-9. 1999
    ..Some rare families have many (4 or more) cases of early onset breast cancer (some of which also include women with ovarian cancer) which are most clearly explained by an autosomal dominant gene with high penetrance...
  3. pmc Germline BRCA2 mutations in men with breast cancer
    E Mavraki
    Imperial Cancer Research Fund, Genetic Epidemiology, St James s Hospital, Leeds, UK
    Br J Cancer 76:1428-31. 1997
    ..One of the frameshifts was detected in the same position as a mutation estimated to be responsible for 40% of all male breast cancer cases in Iceland...
  4. pmc A retrospective observational study of the relationship between family history and survival from colorectal cancer
    E J A Morris
    Colorectal Cancer Epidemiology Group, Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, University of Leeds, Leeds LS9 7TF, UK
    Br J Cancer 108:1502-7. 2013
    ....
  5. pmc The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder
    S C Sak
    Molecular Radiobiology Group, Cancer Research UK Clinical Centre in Leeds, St James s University Hospital, Leeds LS9 7TF, UK
    Br J Cancer 92:2262-5. 2005
    ..98 [0.68-1.42], 0.99 [0.69-1.43] and 1.01 [0.70-1.46]). Moreover, we did not find any significant interaction between these XPC polymorphisms and environmental exposure to cigarette smoking and occupational carcinogens...
  6. pmc Association between family history and mismatch repair in colorectal cancer
    R P Coggins
    Cancer Research UK Genetic Epidemiology Laboratory, St James s University Hospital, Beckett St, Leeds LS9 7TF, UK
    Gut 54:636-42. 2005
    ..This study examines the association between MMR gene expression and family history of cancer among the CRC population...
  7. pmc Plasma osteopontin concentrations in patients with cutaneous melanoma
    A Filia
    Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, St James s University Hospital, Leeds LS9 7TF, UK
    Oncol Rep 30:1575-80. 2013
    ..These findings suggest that plasma osteopontin levels warrant investigation as a tumour marker in a larger study in which the significance of change in levels over time should be studied in relation to detectable disease recurrence...
  8. ncbi Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations
    J A Bishop
    ICRF Genetic Epidemiology Laboratory, Leeds, UK
    J Invest Dermatol 114:28-33. 2000
    ..Until formal gene testing is available, all members of families with an excessive number of melanoma cases should be treated as potential mutation carriers at increased risk of melanoma...
  9. pmc Melanoma sentinel node biopsy and prediction models for relapse and overall survival
    A Mitra
    Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, St James s University Hospital, Beckett Street, Leeds LS97TF, UK
    Br J Cancer 103:1229-36. 2010
    ..To optimise predictive models for sentinal node biopsy (SNB) positivity, relapse and survival, using clinico-pathological characteristics and osteopontin gene expression in primary melanomas...
  10. ncbi A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
    J A Randerson-Moor
    ICRF Genetic Epidemiology Division, ICRF Clinical Centre in Leeds, Cancer Genetics Building, St James s University Hospital, Beckett Street, Leeds LS9 7TF, UK
    Hum Mol Genet 10:55-62. 2001
    ....
  11. pmc Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas
    P Zauber
    Saint Barnabas Medical Center, 22 Old Short Hill Road, Livingstone, NJ 07039, USA
    Mol Pathol 56:137-40. 2003
    ....
  12. pmc Somatic mutations of KIT in familial testicular germ cell tumours
    E A Rapley
    Section of Cancer Genetics, Institute of Cancer Research, Brookes Lawley Building, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Br J Cancer 90:2397-401. 2004
    ..They also lend support to the hypothesis that KIT mutations primarily take place during embryogenesis such that primordial germ cells with KIT mutations are distributed to both testes...
  13. pmc A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer
    N J Froggatt
    Cambridge University, Department of Pathology, UK
    J Med Genet 36:97-102. 1999
    ..2 at 50 years). These intersex differences in colorectal cancer risks have implications for screening programmes and for attempts to identify colorectal cancer susceptibility modifiers...
  14. ncbi Germline mutations of the CDKN2 gene in UK melanoma families
    M Harland
    ICRF Cancer Medicine Research Unit, St James s University Hospital, Beckett Street, Leeds LS9 7TF, UK
    Hum Mol Genet 6:2061-7. 1997
    ..No mutations were detected in exon 2 of CDK4, suggesting that causal mutations in this gene are uncommon. The penetrance of these mutant CDKN2 genes is not yet established, nor is the risk of non-melanoma cancer to gene carriers...
  15. pmc Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q
    H J Thomas
    Imperial Cancer Research Fund Colorectal Unit, London, United Kingdom
    Am J Hum Genet 58:770-6. 1996
    ..Analysis of recombinants and multipoint linkage analysis suggested that the HMPS locus lies in a 4-cM interval containing the D6S283 locus and flanked by markers D6S468 and D6S301...